February 24, 2022 Other Open Access

Meredith Smith; Serena Oliveri; Monica Casiraghi

JSON-LD (schema.org) Export

{
  "description": "<p>We wanted to learn about lung cancer patients&rsquo;&nbsp;preferences for new treaments, and what they considered to be the maximum acceptable risk, and the minimum acceptable benefit of a treatment.</p>", 
  "license": "https://creativecommons.org/licenses/by/4.0/legalcode", 
  "creator": [
    {
      "affiliation": "Alexion", 
      "@type": "Person", 
      "name": "Meredith Smith"
    }, 
    {
      "affiliation": "European Institute of Oncology", 
      "@type": "Person", 
      "name": "Serena Oliveri"
    }, 
    {
      "affiliation": "European Institute of Oncology", 
      "@type": "Person", 
      "name": "Monica Casiraghi"
    }
  ], 
  "url": "https://zenodo.org/record/6260511", 
  "datePublished": "2022-02-24", 
  "keywords": [
    "Plain language summary", 
    "Case study"
  ], 
  "contributor": [
    {
      "affiliation": "KU Leuven", 
      "@type": "Person", 
      "name": "Rosanne Janssens"
    }, 
    {
      "affiliation": "KU Leuven", 
      "@type": "Person", 
      "name": "Isabelle Huys"
    }, 
    {
      "affiliation": "University Medical Centre Utrecht", 
      "@type": "Person", 
      "name": "Ian Smith"
    }, 
    {
      "affiliation": "European Cancer Patient Coalition", 
      "@type": "Person", 
      "name": "Charis Girvalaki"
    }, 
    {
      "affiliation": "University Medical Centre Utrecht", 
      "@type": "Person", 
      "name": "Ardine de Wit"
    }, 
    {
      "affiliation": "Erasmus University Rotterdam", 
      "@type": "Person", 
      "name": "Jorien Veldwijk"
    }, 
    {
      "affiliation": "European Institute of Oncology", 
      "@type": "Person", 
      "name": "Lucilla Lanzoni"
    }
  ], 
  "@context": "https://schema.org/", 
  "identifier": "https://doi.org/10.5281/zenodo.6260511", 
  "@id": "https://doi.org/10.5281/zenodo.6260511", 
  "@type": "CreativeWork", 
  "name": "Treating non-small cell lung cancer: What do patients PREFER"
}